Back to Search
ANNA PAVLICK, DO
DO
Hematology & Oncology Physician
NPI: 1255332839IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
187257(NY)
Education
ROWAN UNIVERSITY SCHOOL OF OSTEOPATHIC MEDICINE
Class of 1990
Research & Publications (20)
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors.
PMID 19221754·Cancer Chemother Pharmacol·2009
3-trial
A phase I and pharmacokinetic study of docetaxel combined with Doxil (pegylated liposomal doxorubicin) without and with granulocyte colony stimulating factor.
PMID 15075667·Anticancer Drugs·2004
3-trial
Novel therapeutic agents under investigation for malignant melanoma.
PMID 12943498·Expert Opin Investig Drugs·2003
6-review
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.
PMID 19666588·Proc Natl Acad Sci U S A·2009
8-other
Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma.
PMID 19643020·BMC Cancer·2009
3-trial
Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma.
PMID 19451711·Chemotherapy·2009
3-trial
Phosphorylated 4E-BP1 is associated with poor survival in melanoma.
PMID 19336517·Clin Cancer Res·2009
8-other
Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma.
PMID 19318491·Clin Cancer Res·2009
8-other
A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma.
PMID 19140204·Cancer·2009
3-trial
Meta-analysis of sentinel lymph node positivity in thin melanoma (<or=1 mm).
PMID 19117354·Cancer·2009
1-meta
Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients.
PMID 19025658·J Transl Med·2008
8-other
Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells.
PMID 19010919·Cancer Res·2008
8-other
Changes in the presentation of nodular and superficial spreading melanomas over 35 years.
PMID 18988292·Cancer·2008
8-other
Shedding of distinct cryptic collagen epitope (HU177) in sera of melanoma patients.
PMID 18829505·Clin Cancer Res·2008
8-other
Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant.
PMID 18566444·J Immunol·2008
3-trial
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.
PMID 18445819·J Natl Cancer Inst·2008
8-other
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group.
PMID 18235116·J Clin Oncol·2008
3-trial
Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors.
PMID 17625806·Cancer Immun·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1305 YORK AVE FL 12
NEW YORK, NY 10021 - Phone
- (646) 962-6444
Quick Facts
- NPI
- 1255332839
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile